| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 06/03/2004 | US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent |
| 06/03/2004 | US20040106594 Phenyl heterocyclyl ethers |
| 06/03/2004 | US20040106582 carbo-or heterocycle-ethynyl-substituted pyridines or pyrimidines; e.g., 2-[2-(pyridine-3-yl)ethynyl]-6-methyl-pyridine |
| 06/03/2004 | US20040106519 Herbicidal composition |
| 06/03/2004 | US20040106007 Electroluminescent iridium compounds with fluorinated phenylpryidines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 06/03/2004 | US20040103820 To enhance light resistance by absorbing ultraviolet (UV) light, provide wettability and stabilize a colorant |
| 06/03/2004 | DE10341864A1 Purifying 2,3-pyridine-dicarboxylic acid used as intermediate for e.g. drugs, by treatment in solution with sulfur source, removal of precipitate and precipitation with acid, giving low heavy metal content |
| 06/03/2004 | DE10254292A1 N-(2-pyridyl)-1-amino-2-propanol production, preferably as (R)- or (S)-enantiomer for use as pharmaceutical intermediate, from deprotonated 2-amino-pyridine and propylene oxide in presence of cuprous salt |
| 06/03/2004 | CA2506415A1 Substituted aryl thioureas and releated compounds; inhibitors of viral replication |
| 06/03/2004 | CA2506297A1 Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors |
| 06/03/2004 | CA2506112A1 Substituted aralkyl derivatives |
| 06/03/2004 | CA2506010A1 A method for deuteration of a heterocyclic ring |
| 06/03/2004 | CA2502705A1 Aryl ureido derivatives and their medical use |
| 06/02/2004 | EP1424382A2 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 06/02/2004 | EP1424340A1 Metal complex photosensitizers and photo-electrochemical cell |
| 06/02/2004 | EP1424328A1 Process for producing 4-dimethyl amino pyridine (4-DMAP) |
| 06/02/2004 | EP1424327A2 4-[(di)alkylamino]pyridines as heat stable supernucleophilic catalysts |
| 06/02/2004 | EP1424326A1 Fused-polycyclic compounds |
| 06/02/2004 | EP1424072A1 N'-(pyridin-3-yl)-(4-phenylpiperazin-1-yl)-carboxyimidamide and -iminothiolate derivatives for the treatment of tumors |
| 06/02/2004 | EP1423379A1 Ortho-substituted aryl amides for controlling invertebrate pests |
| 06/02/2004 | EP1423370A1 Fxr nr1h4 nuclear receptor binding compounds |
| 06/02/2004 | EP1423368A1 Urea and thiourea derivatives as non-nucleoside reverse transcriptase inhibitors |
| 06/02/2004 | EP1423362A1 New mandelic acid derivatives and their use as thrombin inhibitors |
| 06/02/2004 | EP1423357A2 Urea derivatives with antiproteolytic activity |
| 06/02/2004 | EP1423114A2 Method and compositions for treating migraines |
| 06/02/2004 | EP1423092A2 Functional powders for oral delivery |
| 06/02/2004 | EP1423004A1 Herbicidal n-alkylsulfonamino derivatives |
| 06/02/2004 | EP1230249B1 Transition metal complexes with bidentate ligand having an imidazole ring |
| 06/02/2004 | CN1501962A Azo compound and process of producing the same, amd novel compound and process of producing azo compounds using the same |
| 06/02/2004 | CN1501917A Compounds useful as insecticides, compounds useful as acaricides, and processes to use and make same |
| 06/02/2004 | CN1501773A Liquid formulations for dernal application in treatment of parasitic insects in animals |
| 06/02/2004 | CN1500800A Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (HBV) |
| 06/02/2004 | CN1152107C Spiro compound and application as electric fluorescent material material thereof |
| 06/02/2004 | CN1152022C Alpha-substituted. pyrimidine-thioalkyl and alkyl ether compounds |
| 06/02/2004 | CN1152021C Intermediate for preparing corticotropin release factors antagonistic agent and preparing method thereof |
| 06/02/2004 | CN1152016C 2-(3,5-bi-trifluoromethyl-phenyl)-N methyl-N-(6-morpholine-4-yl-4-o-tolyl-pyridine-3-yl)-isobutyramide |
| 06/02/2004 | CN1152015C Piperazine devivatives and preparing method thereof |
| 06/02/2004 | CN1152014C N-aryl anthranilic acid derivatives and uses thereof |
| 06/02/2004 | CN1152007C Pesticides |
| 06/02/2004 | CN1151836C Compounds and compositions for delivering active agents |
| 06/01/2004 | US6743947 Electrochemically stable onium salts and electrolytes containing such for electrochemical capacitors |
| 06/01/2004 | US6743939 Phenylheteroalkylamine derivatives |
| 06/01/2004 | US6743922 3-substituent highly resistant to rotation-4-tertiary amino-pyridine |
| 06/01/2004 | US6743916 Reacting an acetylene compound in the presence of a titanium compound and grignard reagent to obtain organotitanium compound |
| 06/01/2004 | US6743812 Pharmaceutical compositions and methods for use |
| 06/01/2004 | US6743807 Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α |
| 06/01/2004 | US6743790 Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use |
| 06/01/2004 | US6743788 Carbamate and oxamide compounds |
| 06/01/2004 | US6743771 For solubilizing a conformationally altered protein, comprising a carboxylic acid anion of picolinic acid, its analogs, or derivatives thereof and a cation; treating alzheimer's disease or creutzfelds-jakob disease for example |
| 06/01/2004 | US6743373 Reagent based on enantiopure amino acid in which amino group carries activating group to form active precursor of isocyanate group and carboxyl group is substituted; separation of enantiomers having free functional group |
| 06/01/2004 | CA2254362C Composition and method for reducing copper oxide to metallic copper |
| 05/27/2004 | WO2004043974A1 Production of iridium complexes |
| 05/27/2004 | WO2004043940A1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/27/2004 | WO2004043939A1 Amide compounds and methods of using the same |
| 05/27/2004 | WO2004043928A2 N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents |
| 05/27/2004 | WO2004043927A1 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials |
| 05/27/2004 | WO2004043926A1 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist |
| 05/27/2004 | WO2004043925A2 3-substituted-6-aryl pyridined as ligands of c5a receptors |
| 05/27/2004 | WO2004043924A1 2-pyridone derivatives as inhibitors of neutrophile elastase |
| 05/27/2004 | WO2004043911A2 N-cycloalkylglycines as hiv protease inhibitors |
| 05/27/2004 | WO2004043458A1 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 05/27/2004 | WO2004043392A2 Mucin synthesis inhibitors |
| 05/27/2004 | WO2004043379A2 Chemical compounds |
| 05/27/2004 | WO2004032908A9 Method of inhibiting angiogenesis |
| 05/27/2004 | WO2004026816A8 Aromatic liver x-receptor modulators |
| 05/27/2004 | WO2003039549A3 Selective antibacterial agents |
| 05/27/2004 | WO2003000295A3 Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 05/27/2004 | WO2002065977A8 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof |
| 05/27/2004 | US20040102634 For therapy and prophylaxis of hyperglycemia, hyperlipemia and inflammatory disease |
| 05/27/2004 | US20040102626 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use cardiovascular preparations |
| 05/27/2004 | US20040102609 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 05/27/2004 | US20040102517 Novel1,2-diphenylethene derivatives for treatment of immune diseases |
| 05/27/2004 | US20040102513 2'-Substituted 1,1'-biphenyl-2-carboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them |
| 05/27/2004 | US20040102512 Statins reduce or repress T-lymphocyte activation mediated by MHC class II or CD40; new target is alternative to cytokine inhibitors |
| 05/27/2004 | US20040102455 Autoimmune diseases; antiinflammatory agents; antiallergens; viricides; anticancer agents |
| 05/27/2004 | US20040102449 Pyridinyl, pyrimidinyl and pyrazinyl amides as potassium channel openers |
| 05/27/2004 | US20040102441 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 05/27/2004 | US20040102437 Prevention cytokine migration; hypotensive agents; asthma therapy |
| 05/27/2004 | US20040102436 Heterocyclic compound derivatives and medicines |
| 05/27/2004 | US20040102418 Compounds for the treatment of inflammatory disorders |
| 05/27/2004 | US20040102325 Growth inhibiting properties; synthesis |
| 05/27/2004 | US20040102324 Low cost; less toxic; environmentally safer; such as 4-(((1-(2-Chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-5-yl)-carbonyl)amino)-5-methyl-N-1-methylethyl)-3-pyridincarbox-amide |
| 05/27/2004 | US20040101523 Blocking biosynthesis of neurotransmitters; enzyme inhibitors; cardiovascular disorders |
| 05/27/2004 | US20040101446 Arrays and artificial receptors |
| 05/27/2004 | US20040100188 Anthracene derivative and organic electroluminescence device using the derivative |
| 05/27/2004 | US20040099609 Chemical process for the extraction of 2-hydroxy pyridine derivatives, 2-hydroxyquinoline, and 2-hydroxybenzothiazole |
| 05/27/2004 | US20040099603 Method for separating a phase transfer catalyst by means of a membrane |
| 05/27/2004 | CA2765093A1 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 05/27/2004 | CA2505557A1 Mucin synthesis inhibitors |
| 05/27/2004 | CA2505361A1 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist |
| 05/27/2004 | CA2504766A1 2-pyridone derivatives as inhibitors of neutrophile elastase |
| 05/26/2004 | EP1422222A2 Supernucleophilic 4-substituted-pyridine catalysts and processes useful for preparing same |
| 05/26/2004 | EP1422221A1 Novel process for the preparation of 2-aminomethylpyridine derivative |
| 05/26/2004 | EP1422220A1 Process for the preparation of 2-aminomethylpyridine derivative |
| 05/26/2004 | EP1422219A1 Cyclic amine compound |
| 05/26/2004 | EP1421827A1 Organic light emitting devices having carrier blocking layers comprising metal complexes |
| 05/26/2004 | EP1421634A2 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives |
| 05/26/2004 | EP1421071A2 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators |
| 05/26/2004 | EP1421067A1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 05/26/2004 | EP1421066A1 Sulfonylamino derivatives useful as herbicides |